← Back to Fitlife Brands, Inc.
Stoqly stoqly.net Company report Β· October 27, 2026

Fitlife Brands, Inc.

FTLF NasdaqΒ· Medicinal Chemicals & Botanical Products

Last close Β· Oct 26, 2026

$8.32

KIRA Β· Stoqly’s AI analyst, in plain words

  • Fitlife Brands, Inc. had $15.9M of revenue in fiscal 2025, down 75.3% on the year before. Over five years, revenue changed βˆ’6.0% a year on average.
  • Its operating margin was 18.6%, down 1.8Β pts: of every 100 in sales, about 19 is left after running the business.
  • Fitlife Brands, Inc. made $2.0M of net profit in fiscal 2025. From fiscal 2016 to 2025, diluted EPS grew 19.6% a year.
  • Free cash flow was $7.4M in fiscal 2025, 46.4% of revenue.

Market cap

$82.4M

P/E

43.8x

Revenue

$15.9M

Net income

$2.0M

Free cash flow

$7.4M

Operating margin

18.6%

Fitlife Brands, Inc. in 30 seconds Β· fiscal 2025

Weak

Are sales growing?

βˆ’75.3%

No. Sales fell 75.3% last year.

Good

Does it make a profit?

12.7%

Yes. It keeps 12.7% of every sale as profit.

Good

Does profit turn into cash?

46.4%

Yes. 46.4% of sales ends up as free cash.

Weak

How healthy are the accounts?

3 / 8

Weak. It passes 3 of 8 health tests.

For information

How is the share priced?

43.8x

One share costs 43.8 times its yearly profit per share.

What Fitlife Brands, Inc. does

No business description yet.

Fiscal year ends
December 31, 2025
Latest annual report
10-K Β· Mar 31, 2026
Legal name
FITLIFE BRANDS, INC.
CIK
0001374328
stoqly.net Β· FTLF Β· Generated October 27, 2026 Not investment advice Β· Page 1 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Fitlife Brands, Inc. Β· FTLF

Results and finances

The last 5 fiscal years. Amounts in USD.

Fiscal yearFY21FY22FY23FY24FY25
Sales and profit
Revenue $27.9M $28.8M $52.7M $64.5M $15.9M
Revenue growth 28.4% 3.2% 83.0% 22.3% βˆ’75.3%
Net interest income $0.0M $0.1M β€” β€” β€”
Gross margin 44.8% 41.8% 40.7% 43.6% 43.1%
Operating margin 22.3% 19.8% 14.3% 20.3% 18.6%
Net income $5.4M $4.4M $5.3M $9.0M $2.0M
Net margin 19.4% 15.4% 10.0% 13.9% 12.7%
Diluted EPS $1.13 $0.89 $0.54 $0.91 $0.20
Cash
Cash from operations $4.5M $4.1M $4.2M $9.6M $7.4M
Capital expenditure β€” $0.0M $0.1M $0.0M $0.0M
Free cash flow β€” $4.1M $4.1M $9.6M $7.4M
FCF margin β€” 14.3% 7.8% 14.9% 46.4%
Share buybacks $0.4M $0.8M $0.0M β€” β€”
Share count change 322.2% βˆ’99.9% 196,100.0% 0.9% 0.3%
Debt and strength
Cash and short-term investments $9.9M $13.3M $1.1M $4.5M $1.6M
Debt incl. finance leases β€” $0.0M $20.1M $13.1M β€”
Shareholders' equity $17.3M $21.4M $27.0M $36.1M $43.6M
Net debt / EBITDA β€” βˆ’2.3x 2.5x 0.6x β€”
Current ratio 4.4x 5.4x 1.4x 1.6x 1.5x
Interest coverage β€” β€” 7.4x 9.6x 13.6x
Returns and quality
Return on capital β€” 53.5% 12.4% 22.2% β€”
Return on equity 37.0% 22.9% 21.9% 28.4% 5.1%
Return on tangible equity 32.2% 21.2% β€” β€” β€”
Piotroski F-score 4 4 2 8 3
Altman Z'' 8.5 10.4 2.2 4.3 2.0

Insiders bought, 12 months

$0.1M

4 insiders

Insiders sold, 12 months

$0.0M

0 insiders

Of sales under plans

β€”

$0.0M

How to read these numbers

Revenue:
Total sales reported in the income statement.
Operating margin:
Operating income as a share of revenue.
Net income:
Profit after all expenses, interest and tax.
Free cash flow:
Cash from operations minus capital spending.
Net debt / EBITDA:
Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
Return on capital:
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
stoqly.net Β· FTLF Β· Generated October 27, 2026 Not investment advice Β· Page 2 of 3
Stoqly stoqly.net Company report Β· October 27, 2026

Fitlife Brands, Inc. Β· FTLF

Charts and comparison

Ten years at a glance, and how it stacks up against similar companies.

Revenue

Net income

Margins, % of revenue

Gross Operating Net

Cash vs debt (incl. leases)

Cash Debt

Free cash flow

Dividends and buybacks

Dividends Buybacks

KIRA

At $8.32 a share, the company is worth $82.4M: 43.8 times its earnings of the last four quarters.

Source: SEC EDGAR XBRL filings (CIK 0001374328). Data updated October 24, 2026. For information only β€” not investment advice. Check the original filings before relying on any figure.